Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by S. Takashiba
A Novel Lipopolysaccharide-Induced Transcription Factor Regulating Tumor Necrosis Factor Gene Expression: Molecular Cloning, Sequencing, Characterization, and Chromosomal Assignment
Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
Related publications
Adenosine Inhibits Lipopolysaccharide-Induced Cardiac Expression of Tumor Necrosis Factor-
Circulation Research
Cardiovascular Medicine
Physiology
Cardiology
Cloning, Characterization and Expression Analysis of GbWRKY11, a Novel Transcription Factor Gene in Ginkgo Biloba
International Journal of Agriculture and Biology
Agricultural
Biological Sciences
Tumor Necrosis Factor-Α- Or Lipopolysaccharide-Induced Expression of the Murine P-Selectin Gene in Endothelial Cells Involves Novel κB Sites and a Variant Activating Transcription Factor/cAMP Response Element
Journal of Biological Chemistry
Biochemistry
Cell Biology
Molecular Biology
Molecular Cloning and Functional Characterization of the Transcription Factor YY2
Journal of Biological Chemistry
Biochemistry
Cell Biology
Molecular Biology
Gamma Interferon and Lipopolysaccharide Interact at the Level of Transcription to Induce Tumor Necrosis Factor Alpha Expression
Infection and Immunity
Parasitology
Infectious Diseases
Immunology
Microbiology
Tumor Necrosis Factor-Α Inhibits Surfactant Protein C Gene Transcription
Journal of Biological Chemistry
Biochemistry
Cell Biology
Molecular Biology
S-Adenosylmethionine Attenuates the Lipopolysaccharide-Induced Expression of the Gene for Tumour Necrosis Factor Α
Biochemical Journal
Biochemistry
Cell Biology
Molecular Biology
Molecular Cloning and Sequencing of Partial cDNA of Tumor Necrosis Factor and P75 Tumor Necrosis Factor Receptor of Syrian Golden Hamster (Mesocricetus Auratus) With the Use of Universal Primers.
Acta Biochimica Polonica
Biochemistry
Genetics
Molecular Biology
Golimumab: A Novel Anti-Tumor Necrosis Factor
Biologics in Therapy
